IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Update on Nasdaq Listing, page-147

  1. 6,815 Posts.
    lightbulb Created with Sketch. 1718
    Great find, also on Forbes now. With IHL-675A being a combination treatment consisting of hydroxychloroquine and cannabidiol, with the two components working synergistically, the potential for a unique drug for the prevention and treatment of Covid related inflammatory lung conditions looks very promising. Apart from the multi purpose efficacy for rheumatoid arthritis and inflammatory bowel disease.




    Last edited by andres: 13/01/22
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.